Charles River Laboratories International Inc. (CRL)

116.78
1.00 0.91
NYSE : Commercial Services
Prev Close 115.73
Open 115.54
Day Low/High 114.91 / 116.90
52 Wk Low/High 94.15 / 119.05
Volume 159.74K
Avg Volume 309.40K
Exchange NYSE
Shares Outstanding 47.91M
Market Cap 5.60B
EPS 2.60
P/E Ratio 44.12
Div & Yield N.A. (N.A)

Latest News

Charles River Laboratories To Present At Jefferies And William Blair Conferences

Charles River Laboratories To Present At Jefferies And William Blair Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Jefferies 2018 Global Healthcare Conference in New York, New York, on Wednesday, June 6 th, at 11:00 a.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: CRL, DXCM, EVTC, GEC, KRC, WRLD, WWW Downgrades: ACIW, DHT, MDP, PPC, SPKE, SUN, SYMC Initiations: AYX, CLPR, EGC Read on to get TheStreet Quant Ratings' detailed report:

Charles River Laboratories Announces First-Quarter 2018 Results From Continuing Operations

Charles River Laboratories Announces First-Quarter 2018 Results From Continuing Operations

Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the first quarter of 2018.

Charles River Laboratories Announces Extended Relationship With The Michael J. Fox Foundation

Charles River Laboratories Announces Extended Relationship With The Michael J. Fox Foundation

Charles River Laboratories International, Inc. (NYSE: CRL) today announced an extension of its long-standing collaboration with The Michael J.

Charles River Laboratories Expands Services For Early Discovery Screening

Charles River Laboratories Expands Services For Early Discovery Screening

Charles River Laboratories International, Inc. (NYSE: CRL) today announced the expansion of its service capabilities in early discovery screening.

Charles River Laboratories Announces Closing Of Senior Notes Offering

Charles River Laboratories Announces Closing Of Senior Notes Offering

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has closed its previously announced offering of $500 million in aggregate principal amount of its 5.

Charles River Laboratories Completes The Acquisition Of MPI Research

Charles River Laboratories Completes The Acquisition Of MPI Research

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has completed the previously announced acquisition of MPI Research for approximately $800 million in cash, subject to certain customary...

Charles River Laboratories Announces Refinancing Of Credit Facilities And Offering Of $500 Million Of Senior Notes

Charles River Laboratories Announces Refinancing Of Credit Facilities And Offering Of $500 Million Of Senior Notes

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has refinanced its existing $1.

Charles River Laboratories Makes Expansions To Global Biologics Infrastructure

Charles River Laboratories Makes Expansions To Global Biologics Infrastructure

Charles River Laboratories International, Inc. (NYSE: CRL) recently announced several key expansions to its global Biologics Testing Solutions infrastructure to support the characterization, development, and release of...

Charles River Laboratories To Present At Raymond James And Barclays Conferences

Charles River Laboratories To Present At Raymond James And Barclays Conferences

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the Raymond James 39 th Annual Institutional Investors Conference in Orlando, Florida, on Tuesday, March 6 th, at 3:25 p.

Charles River Laboratories Announces New Tumor Model Compendium

Charles River Laboratories Announces New Tumor Model Compendium

Charles River Laboratories International, Inc. (NYSE: CRL) recently announced the launch of its new online Tumor Model Compendium web interface.

Ratings Changes Today

TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,100 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: OMC, WMS Downgrades: ALSK, ATV, BP, CARB, CMP, CRL, DAN, FRT, SNY, VNO, WU, ZIXI Initiations: None Read on to get TheStreet Quant Ratings' detailed report:

Charles River Laboratories Announces Executive Management Appointments

Charles River Laboratories Announces Executive Management Appointments

Charles River Laboratories International, Inc. (NYSE: CRL) today announced two new executive management appointments.

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2017 Results From Continuing Operations And Provides 2018 Guidance

Charles River Laboratories Announces Fourth-Quarter And Full-Year 2017 Results From Continuing Operations And Provides 2018 Guidance

Charles River Laboratories International, Inc. (NYSE:CRL) today reported its results for the fourth-quarter and full-year 2017 and provided guidance for 2018.

Charles River Laboratories To Acquire MPI Research

Charles River Laboratories To Acquire MPI Research

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it has entered into a definitive agreement to acquire MPI Research for approximately $800 million in cash, subject to customary closing...

Charles River Laboratories Makes Investments In High-Throughput Screening Infrastructure

Charles River Laboratories Makes Investments In High-Throughput Screening Infrastructure

Charles River Laboratories International, Inc. (NYSE: CRL) today announced a new agreement which grants Charles River commercial access to AstraZeneca's (NYSE: AZN) high-throughput screening (HTS) and compound management...

Charles River Laboratories Schedules Fourth-Quarter 2017 Earnings And 2018 Guidance Release And Conference Call

Charles River Laboratories Schedules Fourth-Quarter 2017 Earnings And 2018 Guidance Release And Conference Call

Charles River Laboratories International, Inc. (NYSE: CRL) will release fourth-quarter and full-year 2017 financial results and provide 2018 guidance on Tuesday, February 13 th, before the market opens.

IIROC Trading Halt - CRL CRL.WT CRL.RT

IIROC Trading Halt - CRL CRL.WT CRL.RT

Charles River Laboratories Adds Jean-Paul Mangeolle To Board Of Directors

Charles River Laboratories Adds Jean-Paul Mangeolle To Board Of Directors

Charles River Laboratories International, Inc. (NYSE:CRL) today announced the appointment of Jean-Paul Mangeolle, former President of AB SCIEX, to its Board of Directors.

Charles River Laboratories Acquires KWS BioTest

Charles River Laboratories Acquires KWS BioTest

Charles River Laboratories International, Inc. (NYSE: CRL) today announced that it has acquired KWS BioTest, a leading contract research organization (CRO) specializing in in vitro and in vivo discovery testing services...

Charles River Laboratories To Present At J.P. Morgan Healthcare Conference

Charles River Laboratories To Present At J.P. Morgan Healthcare Conference

Charles River Laboratories International, Inc. (NYSE: CRL) announced today that it will present at the 36 th Annual J.

TheStreet Quant Rating: B+ (Buy)